Barinthus Biotherapeutics (BRNS) P/E (2021 - 2026)
Barinthus Biotherapeutics (BRNS) P/E from Apr 30, 2021 to Jul 21, 2026. The TTM Barinthus Biotherapeutics (BRNS) P/E is -0.47. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Barinthus Biotherapeutics (BRNS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.47 | +10.23% |
| 2025 | -0.43 | -45.35% |
| 2024 | -0.78 | -57.23% |
| 2023 | -1.83 | -123.81% |
| 2022 | 7.68 | -297.59% |
| 2021 | -3.88 | N/A |
Comparison Barinthus Biotherapeutics (BRNS) P/E with competitors
Barinthus Biotherapeutics (BRNS) P/E is -0.47.